The role of MDM4 SNP34091 A>C polymorphism in cancer: a meta-analysis on 19,328 patients and 51,058 controls
Int J Biol Markers 2017; 32(1): e62 - e67
Article Type: ORIGINAL RESEARCH ARTICLE
AuthorsXin Jin, Wenchao Zhao, Minghua Zheng, Peng Zhou, Tianli Niu
Cancer is one of the leading causes of death in the world. Several observational studies have suggested a significant association of the MDM4 SNP34091 A>C polymorphism with cancers. However, the results of the published studies are inconsistent.
PubMed, Embase/Ovid and the Chinese National Knowledge Infrastructure were searched for relevant studies with a time limit of April 20, 2016. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were used to evaluate the strength of the association between MDM4 polymorphism and cancer risk. Publication bias was estimated using Begg’s funnel plots and Egger’s regression test.
A total of 19,328 patients and 51,058 controls were included in the analysis. Overall, a significantly decreased risk of cancer was associated with MDM4 SNP34091 polymorphism for the allele model (C vs. A, OR = 0.715, 95% CI: 0.622-0.821, p = 0.000), dominant model (CC + AC vs. AA, OR = 0.684, 95% CI: 0.563-0.831, p = 0.000), recessive model (CC vs. AC + AA, OR = 1.139, 95% CI = 1.055-1.230, p = 0.001) and heterozygote model (AC vs. AA, OR = 0.687, 95% CI = 0.568-0.832). In the subgroup analysis by cancer type, no significant association was found in the breast cancer subgroup. In the subgroup analysis by geographical region, 2 genetic models, the allele and heterozygote models, showed a significant association in Chinese populations.
The results of our meta-analysis showed that the MDM4 SNP34091 A>C polymorphism may function as a protective factor against cancer risk.
- • Received on 29/04/2016
- • Accepted on 21/07/2016
- • Available online on 23/08/2016
- • Published online on 02/03/2017
This article is available as full text PDF.
- Jin, Xin [PubMed] [Google Scholar]
- Zhao, Wenchao [PubMed] [Google Scholar]
- Zheng, Minghua [PubMed] [Google Scholar]
- Zhou, Peng [PubMed] [Google Scholar]
- Niu, Tianli [PubMed] [Google Scholar] , * Corresponding Author (email@example.com)
Department of Urology, The Affiliated Taizhou People’s Hospital of Nantong University, Taizhou, Jiangsu - China
Xin Jin, Wenchao Zhao and Minghua Zheng contributed equally to this work.